PHI with Obstructive bronchitis
How does this condition affect your private health insurance?
Obstructive bronchitis is an inflammation of the bronchial tubes, most commonly triggered by viral infections, leading to airway narrowing and obstruction. It frequently affects young children, presenting with persistent coughing, wheezing, and labored breathing. Increased mucus production further impedes airflow. While typically acute and self-limiting, severe episodes may necessitate medical intervention to relieve respiratory distress. Recurrent occurrences, particularly in childhood, can sometimes indicate underlying airway hypersensitivity or a predisposition to chronic respiratory conditions like asthma or Chronic Obstructive Pulmonary Disease (COPD) in adulthood. Management usually focuses on symptom relief and supporting breathing.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 10%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
1-3 weeks
Duration of Illness (Lifetime)
Recurrent episodes, potentially chronic in some cases
Cost of Treatment (Initial)
€50 - €300 for outpatient care, potentially higher if hospitalization is needed
Cost of Treatment (Lifetime)
€500 - €50,000+ depending on recurrence and progression to chronicity
Mortality Rate
<0.1% for acute episodes in healthy individuals, higher for severe complications or comorbidities
Risk of Secondary Damages
10-30% for increased risk of asthma/COPD later in life with recurrent episodes
Probability of Full Recovery
80-95% for complete recovery from acute episodes without long-term sequelae
Underlying Disease Risk
20-40% for underlying airway hyperreactivity, asthma, or predisposition to COPD